Showing 1,061 - 1,080 results of 132,731 for search '(( a d decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.54s Refine Results
  1. 1061
  2. 1062
  3. 1063

    As the protein lifetime decreases, a trade-off between dynamical and mechanistic error determines fidelity. by Clive G. Bowsher (395875)

    Published 2013
    “…(B–D) Simulated data with as in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002965#pcbi-1002965-g001" target="_blank">Fig. 1A</a>. …”
  4. 1064
  5. 1065
  6. 1066
  7. 1067
  8. 1068

    Chemically inhibiting LDHA or PDK1 decreases cell viability in Aβ resistant cells. by Jordan T. Newington (223389)

    Published 2011
    “…Similarly, 48 hr Aβ exposure significantly decreased cell viability in both PC12 (<b>C</b>) and B12 (<b>D</b>) resistant lines when cells were co-treated with 2.5 mM dichloroacetate (DCA), a chemical inhibitor of PDK1 (*P<0.01). …”
  9. 1069
  10. 1070
  11. 1071
  12. 1072
  13. 1073

    EQ-5D-5L index by different chronic conditions. by Hai Minh Vu (17509346)

    Published 2025
    “…The demographic characteristics and comorbidities of the participants were evaluated, along with their Euroqol-5 dimensions-5 levels (EQ-5D-5L), using a structured questionnaire supplemented by clinical examinations. …”
  14. 1074
  15. 1075
  16. 1076
  17. 1077
  18. 1078

    Decrease in sequencing cost, compared to Moore by Jorge Cañardo Alastuey (539222)

    Published 2014
    “…This is the cost of determining one million bases of a specified quality (see details in [1]). The figure includes a comparison to a hypothetical decrease in cost that had followed Moore's law. …”
  19. 1079
  20. 1080

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”